Zhicheng Yao

6PUBLICATIONS
33CO-AUTHORS
Molecular targetsHaematological tumoursPredictive and prognostic markersCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 11, 2026
Metabolic Dysfunction-associated Steatotic Liver Disease Diminishes the Efficacy of miR-125b-5p-engineered MSC Therapy for Hepatocellular Carcinoma via HK2 Upregulation: A Multimodal Theranostic Study.

|Apr 15, 2025
CircRNA-mTOR Promotes Hepatocellular Carcinoma Progression and Lenvatinib Resistance Through the PSIP1/c-Myc Axis.

Yongchang Tang, Feng Yuan, Mingbo Cao

|May 25, 2023
BRCA1 Insufficiency Induces a Hypersialylated Acidic Tumor Microenvironment That Promotes Metastasis and Immunotherapy Resistance.

Xiaodong Shu, Jianjie Li, Un In Chan

|Jul 16, 2020
circNFATC3 sponges miR-548I acts as a ceRNA to protect NFATC3 itself and suppressed hepatocellular carcinoma progression.

Changchang Jia, Zhicheng Yao, Zexiao Lin

|Aug 07, 2018
Prognostic and Clinicopathological Value of PINX1 in Various Human Tumors: A Meta-Analysis.

Hao Liang, Zhiyong Xiong, Ying Li

|Apr 29, 2014
Delayed laparoscopic cholecystectomy is safe and effective for acute severe calculous cholecystitis in patients with advanced cirrhosis: a single center experience.

Zhicheng Yao, Kunpeng Hu, Pingzhu Huang

Pageof 1

Frequent Collaborators

2 joint publications

Kunpeng Hu

1 joint publications

He Huang

1 joint publications

Bo Liu

1 joint publications

Meihai Deng